WuXi Biologics

WuXi Biologics Launches WuXia293 Platform for Manufacturing Difficult-to-Express Molecules

WuXi Biologics, a top global Contract Research, Development, and Manufacturing Organization (CRDMO), has unveiled a game-changing platform called WuXia293Stable. Built on HEK-293 cells, this innovative solution is designed to help scientists and manufacturers overcome long-standing challenges in producing tough-to-express biologic molecules.

Continue Reading on Meyka

This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.

Read Full Article →

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *